Evidence map›Paper›PMID 35931031›Full record

ArticleCell stem cell2022

Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia.

Ester Gil Vasquez, Nadia Nasreddin, Gabriel N Valbuena, Eoghan J Mulholland, Hayley L Belnoue-Davis, Holly R Eggington, Ryan O Schenck, Valérie M Wouters, Pratyaksha Wirapati, Kathryn Gilroy and 19 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Cell stem cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 110 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 14 institutions in 5 countries.

Ester Gil VasquezWellcome Centre Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK.
Nadia NasreddinWellcome Centre Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK.
Gabriel N ValbuenaWellcome Centre Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK.
Eoghan J MulhollandWellcome Centre Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK.
Hayley L Belnoue-DavisWellcome Centre Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK.
Holly R EggingtonWellcome Centre Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK.
Ryan O SchenckWellcome Centre Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK.
Valérie M WoutersLaboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 Amsterdam, the Netherlands; Oncode Institute, Meibergdreef 9, 1105 Amsterdam, the Netherlands.
Pratyaksha WirapatiSwiss Institute for Bioinformatics, University of Lausanne, Lausanne, Switzerland.
Kathryn GilroyCancer Research UK Beatson Institute, Glasgow, UK.
Tamsin R M LannaganCancer Research UK Beatson Institute, Glasgow, UK.
Dustin J FlanaganCancer Research UK Beatson Institute, Glasgow, UK.
Arafath K NajumudeenCancer Research UK Beatson Institute, Glasgow, UK.
Sulochana OmwengaWellcome Centre Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK.
Amy M B McCorryCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
Alistair EastonDepartment of Oncology, Old Road Campus Research Building, Roosevelt Drive, University of Oxford, Oxford, UK.
Viktor H KoelzerDepartment of Pathology and Molecular Pathology, University and University Hospital Zürich, Rämistrasse 100, 8006 Zürich, Switzerland.
James E EastTranslational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, and Oxford NIHR Biomedical Research Centre, Oxford, UK.
Dion MortonAcademic Department of Surgery, University of Birmingham, Birmingham, UK.
Livio TrusolinoCandiolo Cancer Institute FPO IRCCS, 10060 Candiolo, Torino, Italy.
Timothy MaughanDepartment of Oncology, Old Road Campus Research Building, Roosevelt Drive, University of Oxford, Oxford, UK.
Andrew D CampbellCancer Research UK Beatson Institute, Glasgow, UK.
Maurice B LoughreyCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
Philip D DunneCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
Petros TsantoulisUniversity of Geneva and Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
David J HuelsLaboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 Amsterdam, the Netherlands; Oncode Institute, Meibergdreef 9, 1105 Amsterdam, the Netherlands.
Sabine TejparMolecular Digestive Oncology Unit, KU Leuven, Leuven, Belgium.
Owen J SansomCancer Research UK Beatson Institute, Glasgow, UK; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, UK.
Simon J LeedhamWellcome Centre Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK; Department of Pathology and Molecular Pathology, University and University Hospital Zürich, Rämistrasse 100, 8006 Zürich, Switzerland. Electronic address: simon.leedham@well.ox.ac.uk.
Cancer Research UK Scotland Institute · GBCentre for Human Genetics · GBUniversity of Oxford · GBQueen's University Belfast · GBAmsterdam University Medical Centers · NLCandiolo Cancer Institute · ITJohn Radcliffe Hospital · GBKU Leuven · BEOxford BioMedica (United Kingdom) · GBSIB Swiss Institute of Bioinformatics · CHUniversity Hospital of Zurich · CHUniversity of Birmingham · GBUniversity of Geneva · CHUniversity of Glasgow · GB

Funding

Cancer Research UK A26825Cancer Research UK A28223Department of HealthMedical Research Council MR/M016587/1Wellcome TrustWellcome Trust 090532/Z/09/ZWellcome Trust 206314/Z/17/Z
6 · The paper itself

Abstract

Intestinal homeostasis is underpinned by LGR5+ve crypt-base columnar stem cells (CBCs), but following injury, dedifferentiation results in the emergence of LGR5-ve regenerative stem cell populations (RSCs), characterized by fetal transcriptional profiles. Neoplasia hijacks regenerative signaling, so we assessed the distribution of CBCs and RSCs in mouse and human intestinal tumors. Using combined molecular-morphological analysis, we demonstrate variable expression of stem cell markers across a range of lesions. The degree of CBC-RSC admixture was associated with both epithelial mutation and microenvironmental signaling disruption and could be mapped across disease molecular subtypes. The CBC-RSC equilibrium was adaptive, with a dynamic response to acute selective pressure, and adaptability was associated with chemoresistance. We propose a fitness landscape model where individual tumors have equilibrated stem cell population distributions along a CBC-RSC phenotypic axis. Cellular plasticity is represented by position shift along this axis and is influenced by cell-intrinsic, extrinsic, and therapeutic selective pressures.

Indexed as

Colorectal NeoplasmsIntestinal MucosaAnimalsHomeostasisHumansIntestinesMiceNeoplastic Stem CellsReceptors, G-Protein-CoupledReceptors, G-Protein-Coupledcell plasticitycolorectal cancercolorectal neoplasiaintestinal polypsintestinal stem cellsmolecular phenotypingstem cells

Identifiers

PMID35931031
PMCPMC9592560
OpenAlexW4289792154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.